Written question asked by Tom Morrison (Liberal Democrat) on Friday, 10 April 2026, in the House of Commons. It was due for an answer on Tuesday, 14 April 2026. It was answered by Stephen Kinnock (Labour) on Wednesday, 15 April 2026 on behalf of the Department of Health and Social Care.
ME/CFS: Continuing Care
- Question
-
To ask the Secretary of State for Health and Social Care, what proportion of people diagnosed with Myalgic Encephalomyelitis who applied for NHS Continuing Healthcare funding were (a) assessed as eligible following a Decision Support Tool assessment and (b) refused following a Decision Support Tool assessment in each of the last five years.
- Answer
-
NHS England does not collect data on the proportion of people diagnosed with myalgic encephalomyelitis who are found eligible for NHS Continuing Healthcare (CHC), or any other condition. Eligibility for CHC is not determined by diagnosis or condition, but is assessed on a case-by-case basis taking into account the totality of an individual’s needs, and whether they constitute a ‘primary health need’.
Operational delivery of CHC is the responsibility of integrated care boards (ICBs), including conducting CHC assessments using the standardised Decision Support Tool. NHS England holds ICBs to account, including through robust assurance mechanisms, to ensure they are delivering their statutory functions.
Secondary information
- Type
- Written question
- Reference
- 124951
- Session
- 2024-26
- Subjects
- ME/CFS Finance Continuing care
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-07 09:49:57 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/124951
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/124951
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/124951